Theodore Pincus to Prognosis
This is a "connection" page, showing publications Theodore Pincus has written about Prognosis.
Connection Strength
1.629
-
Update on imaging in rheumatic diseases. Clin Exp Rheumatol. 2018 Sep-Oct; 36 Suppl 114(5):2.
Score: 0.127
-
Limited Value of the Multi-Biomarker Disease Activity Assay Compared to the Routine Assessment of Patient Index Data 3 (RAPID3) Score in the Prognosis of Important Clinical Outcomes in Rheumatoid Arthritis: Comment on the Article by Fleischmann et al and Accompanying Editorial by Davis. Arthritis Rheumatol. 2017 04; 69(4):866-867.
Score: 0.114
-
Electronic multidimensional health assessment questionnaire (eMDHAQ): past, present and future of a proposed single data management system for clinical care, research, quality improvement, and monitoring of long-term outcomes. Clin Exp Rheumatol. 2016 Sep-Oct; 34(5 Suppl 101):S17-S33.
Score: 0.111
-
Electronic eRAPID3 (Routine Assessment of Patient Index Data): opportunities and complexities. Clin Exp Rheumatol. 2016 Sep-Oct; 34(5 Suppl 101):S49-S53.
Score: 0.111
-
Information technology in rheumatology. Clin Exp Rheumatol. 2016 Sep-Oct; 34(5 Suppl 101):1.
Score: 0.111
-
Assessment of fatigue in routine care on a Multidimensional Health Assessment Questionnaire (MDHAQ): a cross-sectional study of associations with RAPID3 and other variables in different rheumatic diseases. Clin Exp Rheumatol. 2016 Sep-Oct; 34(5):901-909.
Score: 0.109
-
Prediction of Remission in a French Early Arthritis Cohort by RAPID3 and other Core Data Set Measures, but Not by the Absence of Rheumatoid Factor, Anticitrullinated Protein Antibodies, or Radiographic Erosions. J Rheumatol. 2016 07; 43(7):1285-91.
Score: 0.107
-
Are patient self-report questionnaires as "scientific" as biomarkers in "treat-to-target" and prognosis in rheumatoid arthritis? Curr Pharm Des. 2015; 21(2):241-56.
Score: 0.098
-
RHEUMDOC: a one-page RHEUMatology DOCtor form with four physician global estimates for overall status, inflammation, damage, and symptoms based on neither inflammation nor damage. Bull Hosp Jt Dis (2013). 2014; 72(2):142-7.
Score: 0.092
-
An evidence-based medical visit for patients with rheumatoid arthritis based on standard, quantitative scientific data from a patient MDHAQ and physician report. Bull NYU Hosp Jt Dis. 2012; 70(2):73-94.
Score: 0.080
-
MDHAQ/RAPID3 can provide a roadmap or agenda for all rheumatology visits when the entire MDHAQ is completed at all patient visits and reviewed by the doctor before the encounter. Bull NYU Hosp Jt Dis. 2012; 70(3):177-86.
Score: 0.080
-
MDHAQ/RAPID3 scores: quantitative patient history data in a standardized "scientific" format for optimal assessment of patient status and quality of care in rheumatic diseases. Bull NYU Hosp Jt Dis. 2011; 69(3):201-14.
Score: 0.074
-
Are patient questionnaire scores as "scientific" as laboratory tests for rheumatology clinical care? Bull NYU Hosp Jt Dis. 2010; 68(2):130-9.
Score: 0.070
-
A biopsychosocial model to complement a biomedical model: patient questionnaire data and socioeconomic status usually are more significant than laboratory tests and imaging studies in prognosis of rheumatoid arthritis. Rheum Dis Clin North Am. 2009 Nov; 35(4):699-712, v.
Score: 0.069
-
Quantitative recording of physician clinical estimates, beyond a global estimate and formal joint count, in usual care: applying the scientific method, using a simple one-page worksheet. Rheum Dis Clin North Am. 2009 Nov; 35(4):813-7, x.
Score: 0.069
-
A practical guide to scoring a Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores in 10-20 seconds for use in standard clinical care, without rulers, calculators, websites or computers. Best Pract Res Clin Rheumatol. 2007 Aug; 21(4):755-87.
Score: 0.059
-
Patient questionnaires and formal education as more significant prognostic markers than radiographs or laboratory tests for rheumatoid arthritis mortality--limitations of a biomedical model to predict long-term outcomes. Bull NYU Hosp Jt Dis. 2007; 65 Suppl 1:S29-36.
Score: 0.056
-
A composite disease activity scale for clinical practice, observational studies, and clinical trials: the patient activity scale (PAS/PAS-II). J Rheumatol. 2005 Dec; 32(12):2410-5.
Score: 0.052
-
American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis. 2011 Mar; 70(3):404-13.
Score: 0.019
-
American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum. 2011 Mar; 63(3):573-86.
Score: 0.019